Evidence map›Paper›PMID 27405491›Full record

ArticleJournal of materials science. Materials in medicine2016

Characterization and cytocompatibility of thermosensitive hydrogel embedded with chitosan nanoparticles for delivery of bone morphogenetic protein-2 plasmid DNA.

Dan-Dan Li, Jian-Feng Pan, Qiu-Xia Ji, Xin-Bo Yu, Ling-Shuang Liu, Hui Li, Xiao-Ju Jiao, Lei Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of materials science. Materials in medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Hydrogels in Oral Disease Management: A Review of Innovations in Drug Delivery and Tissue Regeneration.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Dan-Dan LiStomatological Hospital of Zhengzhou, Zhengzhou, 450000, Henan Province, China.
Jian-Feng PanThe Arrail Dental Hospital of Beijing, Beijing, 100107, Chaoyang Province, China.
Qiu-Xia JiThe Affiliated Hospital of Qingdao University, Qingdao, 266001, Shandong Province, China. jiqx@qduhospital.cn.
Xin-Bo YuThe Affiliated Hospital of Qingdao University, Qingdao, 266001, Shandong Province, China.
Ling-Shuang LiuThe Affiliated Hospital of Qingdao University, Qingdao, 266001, Shandong Province, China.
Hui LiThe Affiliated Hospital of Qingdao University, Qingdao, 266001, Shandong Province, China.
Xiao-Ju JiaoThe Affiliated Hospital of Qingdao University, Qingdao, 266001, Shandong Province, China.
Lei WangThe Affiliated Hospital of Qingdao University, Qingdao, 266001, Shandong Province, China.
Affiliated Hospital of Qingdao University · CNQingdao University · CNBeijing Chaoyang Emergency Medical Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel injectable chitosan thermosensitive hydrogel was designed as a target multi-effect scaffold for endogenous repair of the periodontium. The hydrogel complex was designed by embedding chitosan nanoparticles (CSn) loaded with bone morphogenetic protein-2 plasmid DNA (pDNA-BMP2) into a chitosan (CS)-based hydrogel with α,β-glycerophosphate (α,β-GP), termed CS/CSn(pDNA-BMP2)-GP. Characterization, the in vitro release profile for pDNA-BMP2, and cytocompatibility to human periodontal ligament cells (HPDLCs), were then conducted. The average diameter of the CSn(pDNA-BMP2) was 270.1 nm with a polydispersity index (PDI) of 0.486 and zeta potential of +27.0 mv. A DNase I protection assay showed that CSn could protect the pDNA-BMP2 from nuclease degradation. Encapsulation efficiency and loading capacity of CSn(pDNA-BMP2) were more than 80 and 30 %, respectively. The sol-gel transition time was only 3 min when CSn(pDNA-BMP2) was added into the CS/α,β-GP system. Scanning electron microscopy showed that CSn(pDNA-BMP2) was randomly dispersed in a network with regular holes and a porous structure. Weighting method showed the swelling ratio and degradation was faster in medium of pH 4.0 than pH 6.8. An in vitro pDNA-BMP2 release test showed that the cumulative release rate of pDNA-BMP2 was much slower from CS/CSn-GP than from CSn in identical release media. In release media with different pH, pDNA-BMP2 release was much slower at pH 6.8 than at pH 4.0. Three-dimensional culture with HPDLCs showed good cell proliferation and the Cell-Counting Kit-8 assay indicated improved cell growth with the addition of CSn(pDNA-BMP2) to CS/α,β-GP. In summary, the CS/CSn(pDNA-BMP2)-GP complex system exhibited excellent biological properties and cytocompatibility, indicating great potential as a gene delivery carrier and tissue regeneration scaffold for endogenous repair of the periodontium.

Indexed as

Bone Morphogenetic Protein 2Cell Culture TechniquesCell ProliferationChitosanCulture MediaDNAGene Transfer TechniquesGlycerophosphatesHumansHydrogel, Polyethylene Glycol DimethacrylateHydrogelsHydrogen-Ion ConcentrationKineticsMicroscopy, Electron, TransmissionNanoparticlesPeriodontal Ligamentalpha-glycerophosphoric acidbeta-glycerophosphoric acidBMP2 protein, humanBone Morphogenetic Protein 2ChitosanCulture MediaDNAGlycerophosphatesHydrogel, Polyethylene Glycol DimethacrylateHydrogels

Identifiers

PMID27405491
OpenAlexW2465325180

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.